- Fund Type: FCP
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
DekaLux-BioTech
+ Add to WatchlistDKXBITF:LX
210.49 EUR 4.76 2.21%As of 00:59:30 ET on 05/17/2013.
Snapshot for DekaLux-BioTech (DKXBITF)
| Year To Date: | +34.16% | 3-Month: | +26.65% | 3-Year: | +22.15% | 52-Week Range: | 145.99 - 217.22 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +9.26% | 1-Year: | +37.42% | 5-Year: | - | Beta vs LUXXX: | 0.63 |
Fund Profile & Information for DKXBITF
DekaLux-BioTech is an open-end fund incorporated in Luxembourg. The objective is growth. The Fund invests in equity securities worldwide, that are issued by companies involved in the discovery, research, development, production, distribution, and marketing of biotechnological products for medical applications.
| Inception Date: | 06-02-2008 | Telephone: | 352-3409-39 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.deka.de | ||
Fundamentals for DKXBITF
| NAV | (on 2013-05-17) 210.49 |
|---|---|
| Assets (M) | (on 2013-05-17) 162.58 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for DKXBITF
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | - |
| Dividend Yield (ttm) | - |
Fees & Expenses for DKXBITF
| Front Load | 0.00 |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.18 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | 2.26 |
Top Fund Holdings for DKXBITF
Filing Date: 12/28/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | 84,190 | 10,744,828 | 8.607% |
| Amgen Inc | 147,349 | 9,599,447 | 7.690% |
| Gilead Sciences Inc | 319,200 | 8,762,201 | 7.019% |
| Alexion Pharmaceuticals Inc | 122,600 | 8,679,662 | 6.953% |
| Celgene Corp | 114,600 | 6,809,894 | 5.455% |
| Biogen Idec Inc | 55,440 | 6,194,751 | 4.962% |
| Perrigo Co | 55,450 | 4,334,927 | 3.472% |
| Vertex Pharmaceuticals Inc | 125,600 | 3,966,376 | 3.177% |
| Mylan Inc/PA | 173,000 | 3,578,056 | 2.866% |
| BioMarin Pharmaceutical Inc | 91,300 | 3,357,521 | 2.690% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page